Cargando…
Combined Use of CFTR Correctors in LGMD2D Myotubes Improves Sarcoglycan Complex Recovery
Sarcoglycanopathies are rare limb girdle muscular dystrophies, still incurable, even though symptomatic treatments may slow down the disease progression. Most of the disease-causing defects are missense mutations leading to a folding defective protein, promptly removed by the cell’s quality control,...
Autores principales: | Carotti, Marcello, Scano, Martina, Fancello, Irene, Richard, Isabelle, Risato, Giovanni, Bensalah, Mona, Soardi, Michela, Sandonà, Dorianna |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7084537/ https://www.ncbi.nlm.nih.gov/pubmed/32155735 http://dx.doi.org/10.3390/ijms21051813 |
Ejemplares similares
-
Synthesis
and Evaluation of Bithiazole Derivatives
As Potential α-Sarcoglycan Correctors
por: Ribaudo, Giovanni, et al.
Publicado: (2023) -
Repairing folding-defective α-sarcoglycan mutants by CFTR correctors, a potential therapy for limb-girdle muscular dystrophy 2D
por: Carotti, Marcello, et al.
Publicado: (2018) -
CFTR corrector C17 is effective in muscular dystrophy, in vivo proof of concept in LGMDR3
por: Scano, Martina, et al.
Publicado: (2021) -
Unveiling the degradative route of the V247M α-sarcoglycan mutant responsible for LGMD-2D
por: Bianchini, Elisa, et al.
Publicado: (2014) -
Modeling Sarcoglycanopathy in Danio rerio
por: Dalla Barba, Francesco, et al.
Publicado: (2023)